CEFAZOLIN IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Cefazolin In Plastic Container patents expire, and what generic alternatives are available?
Cefazolin In Plastic Container is a drug marketed by Baxter Hlthcare Corp and is included in one NDA.
The generic ingredient in CEFAZOLIN IN PLASTIC CONTAINER is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefazolin In Plastic Container
A generic version of CEFAZOLIN IN PLASTIC CONTAINER was approved as cefazolin sodium by SANDOZ on December 9th, 1988.
Summary for CEFAZOLIN IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 157 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CEFAZOLIN IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for CEFAZOLIN IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Abdul El-Rabbany | Phase 4 |
Assistance Publique Hopitaux De Marseille | Phase 4 |
Leiden University Medical Center | Phase 4 |
Pharmacology for CEFAZOLIN IN PLASTIC CONTAINER
Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for CEFAZOLIN IN PLASTIC CONTAINER
US Patents and Regulatory Information for CEFAZOLIN IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare Corp | CEFAZOLIN IN PLASTIC CONTAINER | cefazolin sodium | SOLUTION;INTRAVENOUS | 207131-002 | Feb 1, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Baxter Hlthcare Corp | CEFAZOLIN IN PLASTIC CONTAINER | cefazolin sodium | SOLUTION;INTRAVENOUS | 207131-001 | Aug 7, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |